ViraCyte LLC
New Brighton, United States · Founded 2017 · $3.8M raised
- Headquarters
- New Brighton, Minnesota
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $3.8M
- Last Round
- $3.8M Grant
- Rounds
- 1
About
ViraCyte LLC was a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic T cell therapies for severe viral infections in immunocompromised patients. Spun out of Baylor College of Medicine, its lead product Viralym-B targeted BK virus infection in hematopoietic stem cell transplant recipients. The company later rebranded as AlloVir and subsequently became Kalaris Therapeutics.
Summary
ViraCyte LLC is a Biotech company based in New Brighton, United States, founded in 2017. It has raised $3.8M in total across 1 round. Investors include National Institutes of Health.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/viracyte-llc"><img src="https://indexed.vc/api/badge/company/viracyte-llc" alt="ViraCyte LLC on Indexed.vc" width="260" height="76" /></a>